Hospital do Rim e Hipertensao Fundacao Oswaldo Ramos

São Paulo 04038-002

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Obesity, Type 2 Diabetes

Studies at this site

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed